SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001453687-24-000072
Filing Date
2024-04-22
Accepted
2024-04-22 06:25:14
Documents
13
Period of Report
2024-04-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rnac-20240419.htm   iXBRL 8-K 27830
  Complete submission text file 0001453687-24-000072.txt   151094

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20240419.xsd EX-101.SCH 1948
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20240419_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20240419_pre.xml EX-101.PRE 12550
16 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20240419_htm.xml XML 2728
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 24859473
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)